申请人:Janssen Pharmaceutica NV
公开号:US20170327492A1
公开(公告)日:2017-11-16
The present invention comprises methods of making 5-(2,3-dichloro-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl)-N-(2-hydroxy-2-methylpropyl)-4-(R
1
-1-carbonyl)thiazole-2-carboxamide, wherein R
1
is defined in the specification.